Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,569 | 2,916 | 7,034 | 5,397 | -35 |
| Depreciation Amortization | 44,443 | 21,338 | 89,093 | 72,102 | 50,415 |
| Income taxes - deferred | 5,644 | 1,730 | 6,477 | 10,221 | 2,149 |
| Accounts receivable | -12,074 | -1,567 | -10,742 | -1,943 | -1,046 |
| Accounts payable and accrued liabilities | 2,248 | -936 | -5,598 | -2,669 | 9,344 |
| Other Working Capital | 4,311 | -11,566 | -40,441 | -55,380 | -36,752 |
| Other Operating Activity | 30,999 | 13,765 | 106,171 | 80,577 | 23,396 |
| Operating Cash Flow | $83,140 | $25,680 | $151,994 | $108,305 | $47,471 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -1,250 | -1,250 | -1,250 |
| PPE Investments | -4,060 | -2,724 | -15,333 | -15,115 | -11,245 |
| Net Acquisitions | -335 | -335 | -16,702 | -16,702 | -16,702 |
| Purchase Of Investment | -3,905 | N/A | -141,041 | -113,450 | -74,685 |
| Sale Of Investment | 39,500 | 22,500 | 273,807 | 226,665 | 140,416 |
| Investing Cash Flow | $31,200 | $19,441 | $99,481 | $80,148 | $36,534 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 101,000 | 101,000 | N/A |
| Debt Repayment | -10,000 | -5,000 | -317,799 | -312,799 | -6,563 |
| Common Stock Issued | 2,181 | 2 | 3,303 | 1,581 | 1,569 |
| Common Stock Repurchased | -50,045 | -50,045 | -148,328 | -100,080 | -50,039 |
| Other Financing Activity | -9,184 | -4,355 | -7,803 | -7,677 | -5,466 |
| Financing Cash Flow | $-67,048 | $-59,398 | $-369,627 | $-317,975 | $-60,499 |
| Exchange Rate Effect | 38 | 38 | -77 | 337 | 204 |
| Beginning Cash Position | 158,545 | 158,545 | 276,774 | 276,774 | 276,774 |
| End Cash Position | 205,875 | 144,306 | 158,545 | 147,589 | 300,484 |
| Net Cash Flow | $47,330 | $-14,239 | $-118,229 | $-129,185 | $23,710 |
| Free Cash Flow | |||||
| Operating Cash Flow | 83,140 | 25,680 | 151,994 | 108,305 | 47,471 |
| Capital Expenditure | -4,060 | -2,724 | -15,333 | -15,115 | -11,245 |
| Free Cash Flow | 79,080 | 22,956 | 136,661 | 93,190 | 36,226 |